https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Five healthcare trajectories in the year before suicide and what they tell us about opportunities for prevention: a population-level case series study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51939 Wed 28 Feb 2024 15:27:44 AEDT ]]> Noncommunicable diseases, access to essential medicines and universal health coverage https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42167 Wed 13 Mar 2024 09:41:25 AEDT ]]> A preliminary analysis of the pharmaceutical provisions in the Australia-United States Free Trade Agreement on prescription medicines in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5845 Wed 11 Apr 2018 18:51:17 AEST ]]> Costs of medicines and health care: a concern for Australian women across the ages https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14771 Wed 11 Apr 2018 16:01:48 AEST ]]> An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15671 Wed 11 Apr 2018 14:48:42 AEST ]]> Accuracy of self-reported medicines use compared to pharmaceutical claims data amongst a national sample of older Australian women https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16082 80%). Specificity was consistently high across all classes, suggesting women could accurately report using a medicine. Pharmaceutical claims data can assist evaluation of judicious medicines use, changes to availability and uptake of medicines, and track medicine expenditure for chronic conditions. Over-the-counter medicines, medicines not covered by pharmaceutical subsidies and those used on an as needed basis may be best measured by self-report, as use may be underestimated using pharmaceutical claims data.]]> Wed 11 Apr 2018 13:33:11 AEST ]]> Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+years in China and India: results from the WHO study on global AGEing and adult health (SAGE) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30965 Wed 11 Apr 2018 13:07:37 AEST ]]> Assessing medication packaging and labelling appropriateness in Sri Lanka https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26702 Wed 11 Apr 2018 10:47:19 AEST ]]> Access to cytotoxic medicines by children with cancer: a focus on low and middle income countries https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24082 Thu 28 Oct 2021 13:02:20 AEDT ]]> Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7012 Sat 24 Mar 2018 08:38:05 AEDT ]]> Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19176 Sat 24 Mar 2018 07:52:18 AEDT ]]> Grafting to improve bitter melon (Mormodica charantia L.) productivity and fruit quality https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35866 Mon 16 Dec 2019 17:14:27 AEDT ]]> Introducing augmented reality technology to enhance learning in pharmacy education: a pilot study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40390 p < 0.0001, and that students found using AR was stimulating, interactive, engaging and easy to follow. Thus, AR technology could be an effective way to enhance student learning about medicines.]]> Mon 11 Jul 2022 11:21:37 AEST ]]>